Enhanced muscarinic M1 receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Gireesh, G ^a   Kumar, T Peeyush ^a   Mathew, Jobin ^a   Paulose, Cs ^a  

^a Department of Physics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; INSULIN; INSULIN ZINC SUSPENSION; MUSCARINIC M1 RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN NUCLEUS; BRAIN REGION; CHOLINERGIC ACTIVITY; CONTROL GROUP; CONTROLLED STUDY; CORPUS STRIATUM; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; INSULIN TREATMENT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RECEPTOR GENE; ANIMAL; BINDING SITE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; BINDING SITES; CORPUS STRIATUM; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; INSULIN; MALE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1;

EID: 65649084039     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-38     Document Type: Article

References (54)

1. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. F Kreier A Yilmaz A Kalsbeek JA Romijn HP Sauerwein E Fliers RM Buijs, Diabetes 2003 52 2652 2656 14578282 (Pubitemid 37339693)
2. Reduced anorexic and locomotor - stimulant action of d-amphetamine in alloxan - diabetic rats. JF Marchall TG Friedman MI Heffner, Brain Research 1976 111 428 432 949615
3. Further analysis of the resistance of the diabetic rat to d-amphetamine. JF Marchall, Pharmacol Biochem Behav. 1978 8 3 281 286 565933 (Pubitemid 8313403)
4. Morphological changes in the hypothalamic-hypophyseal-gonodal axis of male rats after twelve months of streptozotocin induced diabetes. GL Rossi G Bestetti, Diabetologia 1981 21 476 481 7028562 (Pubitemid 11027870)
5. Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetes. E Reske-Nielsen K Lunbeak, Acta Neurol Scand Suppl. 1963 39 4 Suppl 4 273 293 14057514
6. Dopamine, norepinephrine and serotonin in the brain of diabetic rats and man. Z Lackovic M Salkovic Z Kuci M Relja, Journal of Neurochemistry 1985 44 94 98 3964838
7. Dibetes induced alterations in brain monoamine metabolism in rats. M Bitar M Koulu SI Rapoport M Linnoila, Journal of Pharmacology and Experimental Therapeutics 1986 236 432 437 (Pubitemid 16184238)
8. Dopaminergic activity is reduced in diabetic rats. CF Saller, Neuroscience Letters 1984 49 301 306 6493613 (Pubitemid 14067945)
9. Classification of muscarinic acetylcholine receptors. MP Caulfield NJM Birdsall, Pharmacol Rev 1998 50 279 290 9647869
10. The concentrations of dopamine 5 Hydroxytryptamine and some of their acid metabolites in the brain of genetically diabetic rats. RPS Kwok EK Walls AV Juoria, Neurochemical Research 1985 10 611 616 2409457 (Pubitemid 15087640)
11. Effects of short and long-lasting diabetes mellitus on mouse brain monoamines. CC Chen JC Yang, Brain Research 1991 552 175 179 1913176
12. Brain catecholamine concentrations in hyperosmolar diabetic and diabetic rats. Y Tasaka H Matsumoto Y Inove Y Hirata, Diabetes Research 1992 19 1 7 1468182
13. Decreased muscarinic M1 receptor gene expression in the hypothalamus, brainstem, and pancreatic islets of streptozotocin-induced diabetic rats. G Gireesh SB Kaimal TP Kumar CS Paulose, J Neurosci Res 2007
14. Decreased muscarinic M1 receptor gene expression in the cerebral cortex of streptozotocin-induced diabetic rats and Aegle marmelose leaf extract's therapeutic function J. G Gireesh SK Reas M Jobin CS Paulose, Ethnopharmacol 2007
15. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. AI Levey CA Kitt WF Simonds DL Price MR Brann, J Neurosci 1991 11 3218 3226 1941081
16. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distributions of m4 and m5 receptors in rat brain. RP Yasuda W Ciesla LR Flores SJ Wall M Li SA Satkus JS Weisstein BV Spagnola BB Wolfe, 1993 43 149 157 8429821
17. Diabetogenic action of Streptozotocin: Relationship of dose to metabolic response. A Junod AE Lambert W Staufferacher AE Renold, J Clin Invest 1969 48 2129 2139 4241908
18. Kidney functions in experimental diabetic ketosis. M Hohenegger B Rudas, Diabetologia 1971 17 334 338
19. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. RN Arison EI Ciaccio MS Glitzer AV Cassaro M Pruss, Diabetes 1967 16 51 56 6015682
20. 3H] dopa in various regions of brain. J Glowinski LL Iversen, J Neurochem 1966 13 655 669 5950056
21. A new and rapid colorimetric determination of acetylcholinesterase activity. GL Ellman KD Courtney V Andres RM Featherstone, Biochem Pharmacol 1961 7 88 95 13726518
22. 3H] QNB in rat brain. Proc. HI Yamamura G Synder, Natl Acad Sci 1981 71 1725 1729
23. Protein measurement with Folin Phenol reagent. OH Lowry NJ Roserbrough AL Farr RJ Randall, J Biol Chem 1951 193 265 275 14907713
24. The attraction of proteins for small molecules and ions. G Scatchard, Ann N Y Acad Sci 1949 51 660 672
25. Therapeutic opportunities for muscarinic receptors in the central nervous system. CC Felder FP Bymaster J Ward N DeLapp, J Med Chem 2000 43 4333 4353 11087557 (Pubitemid 32046857)
26. Molecular biology of muscarinic acetylcholine receptors. J Wess, Crit Rev Neurobiol 1996 10 69 99 8853955 (Pubitemid 26283956)
27. Muscarinic receptor subtype pharmacology and physiology. RM Eglen, Prog Med Chem 2005 43 105 136 15850824 (Pubitemid 40605496)
28. The importance of cell failure in the development and progression of type 2 diabetes. SE Kahn, J Clin Endocrinol Metab 2001 86 4047 4058 11549624
29. Autonomic regulation of islet hormone secretion - implications for health and disease. B Ahren, Diabetologia 2000 43 393 410 10819232 (Pubitemid 30237947)
30. Mechanisms and physiological significance of the cholinergic control of pancreatic cell function. P Gilon JC Henquin, Endocr Rev 2001 22 565 604 11588141 (Pubitemid 32958576)
31. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. J Wess, Annu Rev Pharmacol Toxicol 2004 44 423 450 14744253 (Pubitemid 38263848)
32. Induction of DNA synthesis in primary culture of rat hepatocyte by serotonin: Possible involvement of serotonin S2 receptor. B Sudha CS Paulose, Hepatology 1998 27 62 66 9425918 (Pubitemid 28041535)
33. Hepatic GABA A receptor functional regulation during liver cell proliferation. MP Biju S Pyroja NV Rajesh CS Paulose, Hepatol Res 2001 21 136 146 11551834 (Pubitemid 32899084)
34. Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rat. TR Renuka DV Ani CS Paulose, Life Sci 2004 75 2269 2280 15350825 (Pubitemid 39180036)
35. Decreased 5-HT1A receptor gene expression and 5HT1A receptor protein in the cerebral cortex and brain stem during pancreatic regeneration in rats. VV Mohanan SB Kaimal CS Paulose, Neurochem Res 2005 30 25 32 15756929 (Pubitemid 40254201)
36. Decreased GABAA receptor function in the brain stem during pancreatic regeneration in rats. SB Kaimal G Gireesh CS Paulose, Neurochem Res 2007 17721726 (Pubitemid 47497883)
37. Age related alterations in noradrenergic function in brain stem of streptozotocin-diabetic rats. A Abraham CS Paulose, J Biochem Mol Biol Biophys 1999 31 171 176 (Pubitemid 30025635)
38. Immunological localization of M 1 -M 5 muscarinic acetylcholine receptors in peripheral tissues and brain. AI Levey, Life Sci 1993 52 441 48 8441326
39. Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors. MT Vilar G Mengod JM Palacios, Prog Brain Res. 1993 98 95 101 8248542 (Pubitemid 23305634)
40. Development of selective antisera for muscarinic cholinergic receptor subtypes. BB Wolfe RP Yasuda, Ann NY Acad Sci 1995 757 186 93 7611674
41. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. R Quirion I Aubert PA Lapchak RP Schaum S Teolis, Trends Pharmacol Sci. 1989 10 80 84 (Pubitemid 20004469)
42. M 1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. A Fisher E Heldman D Gurwitz R Haring Y Karton, Ann NY Acad Sci 1996 177 189 196
43. A mapping of the distribution of acetylcholine, choline acetyltransferase and acetylcholinesterase in discrete areas of rat brain. DB Hoover EA Muth DM Jacobowitz, Brain Res 1978 153 295 306 687983 (Pubitemid 8387959)
44. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. DM Weiner AI Levey MR Brann, Proc Natl Acad Sci USA 1990 87 7050 7054 2402490 (Pubitemid 20325203)
45. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. V Bernard E Normand B Bloch, J Neurosci 1992 12 3591 600 1527598
46. Neural modulation of glucose-dependent insulinotropic peptide (GIP) and insulin secretion in conscious dogs. GR Greenberg S Pokol-Daniel, Pancreas 1994 9 531 535 7937701 (Pubitemid 24191723)
47. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters. MT Tassava T Okuda DR Romsos, Am J Physiol 1992 262
48. Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. TP Iismaa EA Kerr JR Wilson L Carpenter N Sims TJ Biden, Diabetes 2000 493 92 398 (Pubitemid 30131784)
49. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. AE Reyes DR Perez A Alvarez J Garrido MK Gentry BP Doctor NC Inestrosa, Biochem Biophys Res Commun 1997 232 652 655 9126330 (Pubitemid 27214052)
50. Quantitative development and molecular forms of acetylcholinesterase and butyrylcholinesterase during morphogenesi s and synaptogenesi s of chick brain and retina. PG Layer R Alber O Sporns, J Neurochem 1987 49 175 182 3585328 (Pubitemid 17108246)
51. CNS-endocrine pancreas system. IV. Evidence for the existence of a direct hypothalamic-vagal descending pathway. IG Akmayev E Rubberia OV Fiddina, Endokrinologie 1978 71 169 174 668640 (Pubitemid 8331431)
52. Bindingof selective antagonists to four muscarinic receptors (M1 - M4) in rat forebrain. M Waelbroeck M Tastenoy J Camus J Christophe, Mol Pharmacol 1990 38 267 273 2385234
53. Regional distribution of M 1, M2 and non- Ml, non-M2 subtypes of muscarinic binding sites in rat brain. F Ehlert LLP Tran, J Pharmacol Exp Ther 1990 255 1148 1157 2262898
54. Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain. S Sugita NU Chimura ZG Jiang R North, Proc Natl Acad Sci USA 1991 88 2608 2611 1672454 (Pubitemid 21916467)